SUNLINK HEALTH SYSTEMS INC

SSY

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
SSY
CIK0000096793
SIC8062
SectorServices
Industry CategoryHealthcare
Industry GroupServices – Health

Contact

Address900 CIRCLE 75 PARKWAY, SUITE 690, ATLANTA, GA, 30339
Website sunlinkhealth.com
Phone7709337000
CEORobert M. Thornton
Employees1,376

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$33.65 million
Pre-Tax Income$175,000.00
Net Income$-1.00 million
Net Income to Common$-956,000.00
EPS$-0.15
View All
Balance Sheet
Cash$7.47 million
Assets$17.47 million
Liabilities$4.06 million
Common Equity$13.41 million
Liabilities & Equity$17.47 million
View All
Calculations
NOPAT$-704,457.10
EBITDA$605,000.00
Price to EarningsN/A
Price to Book$0.42
ROE-6.35%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

SunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter Results

ATLANTA, May 13, 2025--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $630,000 (or a loss of $0.09 per fully diluted share) for its third fiscal quarter ended March 31, 2025 compared to a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for the third fiscal quarter ended March 31, 2025. Net loss for the quarter ended March 31, 2025 was $671,000 (or a loss of $0.10 per fully diluted share) compared to

Article Link

REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTION

Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the “merger agreement”), pursuant to which SunLink will merge with and into Regional (the “merger”) in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock a

Article Link

SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results

ATLANTA, February 12, 2025--SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results.

Article Link

SunLink Joins Forces With Regional Health Properties In All-Stock Deal: Shares Surge

Regional Health Properties, Inc. (AMEX:RHE) and SunLink Health Systems, Inc. (AMEX:SSY) shares traded higher after the companies disclosed a merger agreement. As part of the deal, Regional Health Properties will issue 1.41 million shares of common stock and 1.41 million shares of newly authorized Series D 8% Cumulative Convertible Redeemable Preferred Stock. Notably, for every five shares of SunLink common stock, Regional will issue one share of common stock and, subject to adjustments, one shar

Article Link

SunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter Results

ATLANTA, November 12, 2024--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2024 compared to a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for the first fiscal quarter ended September 30, 2023. During the quarter ended September 30, 2024, the Company sold non-core assets for cash totaling $1,465,

Article Link